News

Upcoming call: Alliance for Language Technologies

Published on | 1 year ago

Programmes AI Continent

The European Commission has published a new call (one call topic) under the Digital Europe programme: Alliance for Language Technologies (DIGITAL-2024-AI-B-06-LANGUAGE).

The call is expected to open on 1 August 2024, deadline to submit proposals will be 26 September 2024.

With this call, the Commission aims to federate Member States efforts to preserve the linguistic and cultural diversity in Europe while effectively implementing the European Common Data Infrastructure and Service MCP’s objectives in the area of language technologies. By providing the necessary data and model adaptation capacities, the action will have a strong impact on the deployment of large language foundation models and their applications such as generative AI.

The relevant information on objectives, scope and conditions of participation can be found in the call document

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1779 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.